Harvest Trading Cap's first social project ¨A roof for my grandfather¨
March 07, 2022 09:57 ET
|
Harvest Trading Cap
MIAMI, March 07, 2022 (GLOBE NEWSWIRE) -- Mr. Jairo Gonzalez, CEO of Harvest Trading Cap, and his entourage were present in the municipality of Santa Ana on March 2, 2022. They were formally...
Jairo Gonzalez & The Harvest Academy Educate Financially in a Crypto World
February 08, 2022 17:04 ET
|
Harvest Trading Cap
A Media Snippet accompanying this announcement is available by clicking on the image or link below: MIAMI, Feb. 08, 2022 (GLOBE NEWSWIRE) -- The last few years have seen new financial...
Jairo González CEO da Harvest Trading Cap se torna o primeiro dominicano a criar uma criptomoeda
January 18, 2022 16:05 ET
|
Harvest Trading Cap
MIAMI, Jan. 18, 2022 (GLOBE NEWSWIRE) -- O grupo financeiro dominicano Harvest Trading Cap, à mão de Jairo González, nasceu em 2015, é uma empresa dedicada a assessorar investimentos no mercado...
Jairo Gonzalez, PDG de Harvest Trading Cap, devient le premier Dominicain à créer une cryptomonnaie
January 18, 2022 16:05 ET
|
Harvest Trading Cap
MIAMI, 18 janv. 2022 (GLOBE NEWSWIRE) -- Le groupe financier dominicain Harvest Trading Cap, une société dédiée au conseil en investissement sur les marchés financiers, qui se donne pour mission de...
Jairo Gonzalez CEO of Harvest Trading Cap becomes first Dominican to create a cryptocurrency
January 18, 2022 16:05 ET
|
Harvest Trading Cap
MIAMI, Jan. 18, 2022 (GLOBE NEWSWIRE) -- The Dominican financial group Harvest Trading Cap by the hand of Jairo Gonzalez was created in 2015, a company dedicated to investment advisory in financial...
The Global Pneumonia Therapeutics Market Estimated to Generate a Revenue of $3,147.7 Million by 2027, Growing at a CAGR of 8.2% From 2020-2027 – Informative Report [230 Pages] by Research Dive
August 03, 2021 09:30 ET
|
Research Dive
New York, USA, Aug. 03, 2021 (GLOBE NEWSWIRE) -- According to a report published by Research Dive, the global pneumonia therapeutics market is expected to generate a revenue of $3,147.7 million by...
Admera Health Announces Appointment of Omar Karame as Chief Financial Officer
December 10, 2019 11:45 ET
|
Admera Health, LLC
SOUTH PLAINFIELD, N.J., Dec. 10, 2019 (GLOBE NEWSWIRE) -- Admera Health, a molecular diagnostics company, welcomes Omar Karame as Chief Financial Officer to the company. Mr. Karame brings to Admera...
Interpace Enters Strategic Partnership Agreement with Genecast Biotechnology to Partner with Biopharma Solutions in China
September 16, 2019 06:55 ET
|
Interpace Diagnostics Group, Inc.
PARSIPPANY, NJ, Sept. 16, 2019 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc.’s subsidiary, Interpace BioPharma Inc. (“Interpace”, “Interpace BioPharma” or the “Company”) today announced that...
Interpace Diagnostics Labs Receive College of American Pathology (CAP) Accreditation
April 25, 2019 06:55 ET
|
Interpace Diagnostics Group, Inc.
Pennsylvania and Connecticut Labs Both Receive Accreditation PARSIPPANY, NJ, April 25, 2019 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (NASDAQ: IDXG) announced today that it has...
Admera Health Expands Liquid Biopsy Offering to Include Detection of Copy Number Variation and Microsatellite Instability
October 23, 2018 09:13 ET
|
Admera Health, LLC
SOUTH PLAINFIELD, N.J., Oct. 23, 2018 (GLOBE NEWSWIRE) -- At CAP18, in Chicago, IL, Admera Health (www.admerahealth.com), unveiled an expansion to its next generation sequencing (NGS) based...